Joerg Moeller, MD is the global Head of Research and Development (R&D) at LEO Pharma A/S. Prior to his current role, he was the global Head of R&D and a member of the Executive Committee of Bayer AG’s Pharmaceuticals Division. He also served as a member of the board of directors at BlueRock Therapeutics and Casebia Therapeutics. Under his leadership, the R&D function has developed and implemented a global innovation model emphasizing productive, innovative collaboration models with leading academic institutions, small and large biotech players and established pharmaceutical companies. During his career he lead the development of a variety of innovation drugs to global approvals.